We are live on ! Find out more
US Bancorp

US Bancorp Portfolio holdings

AUM $82.4B
1-Year Est. Return 19.69%
This Fund
S&P 500
This Quarter Est. Return
-0.8%
1 Year Est. Return
+19.69%
3 Year Est. Return
+59.6%
5 Year Est. Return
+69.89%
10 Year Est. Return
+246.63%
AUM
$74.9B
AUM Growth
-$1.53B
Cap. Flow
-$190M
Cap. Flow %
-0.25%
Top 10 Hldgs %
34.07%
Holding
4,428
New
282
Increased
1,508
Reduced
1,702
Closed
242

Sector Composition

Rank Sector Weight
1 Technology 12.72%
2 Financials 8.33%
3 Healthcare 6.69%
4 Industrials 4.98%
5 Consumer Staples 4.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KXI icon
3651
iShares Global Consumer Staples ETF
KXI
$1.03B
$4.87K ﹤0.01%
76
NWBI icon
3652
Northwest Bancshares
NWBI
$2.25B
$4.8K ﹤0.01%
399
EQC
3653
DELISTED
Equity Commonwealth
EQC
$4.78K ﹤0.01%
2,971
-14
-0.5% -$24
ADNT icon
3654
Adient
ADNT
$1.6B
$4.76K ﹤0.01%
370
-161
-30% -$2.59K
CTMX icon
3655
CytomX Therapeutics
CTMX
$705M
$4.7K ﹤0.01%
7,392
-23,400
-76% -$18.1K
CAF
3656
Morgan Stanley China A Share Fund
CAF
$334M
$4.67K ﹤0.01%
357
-125
-26% -$1.59K
SPTL icon
3657
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
$10.5B
$4.67K ﹤0.01%
171
-12,209
-99% -$325K
EEMA icon
3658
iShares MSCI Emerging Markets Asia ETF
EEMA
$827M
$4.67K ﹤0.01%
63
-112
-64% -$8.27K
OPLN
3659
Openlane
OPLN
$4.17B
$4.63K ﹤0.01%
240
-12
-5% -$248
CLDX icon
3660
Celldex Therapeutics
CLDX
$2.77B
$4.57K ﹤0.01%
252
-257
-50% -$5.74K
VFQY icon
3661
Vanguard US Quality Factor ETF
VFQY
$474M
$4.54K ﹤0.01%
34
TBPH icon
3662
Theravance Biopharma
TBPH
$874M
$4.51K ﹤0.01%
505
+146
+41% +$1.36K
OCUL icon
3663
Ocular Therapeutix
OCUL
$1.86B
$4.51K ﹤0.01%
615
+298
+94% +$2.29K
SCHI icon
3664
Schwab 5-10 Year Corporate Bond ETF
SCHI
$11.4B
$4.49K ﹤0.01%
200
-832
-81% -$18.5K
BRSP
3665
BrightSpire Capital
BRSP
$681M
$4.45K ﹤0.01%
800
+88
+12% +$514
ASGI
3666
abrdn Global Infrastructure Income Fund
ASGI
$776M
$4.32K ﹤0.01%
235
-85
-27% -$1.52K
FNA
3667
DELISTED
Paragon 28, Inc.
FNA
$4.31K ﹤0.01%
330
+103
+45% +$1.28K
DFAU icon
3668
Dimensional US Core Equity Market ETF
DFAU
$12.3B
$4.3K ﹤0.01%
+112
New +$4.54K
PSCH icon
3669
Invesco S&P SmallCap Health Care ETF
PSCH
$161M
$4.29K ﹤0.01%
99
VNET
3670
VNET Group
VNET
$2.05B
$4.28K ﹤0.01%
522
HUMA icon
3671
Humacyte
HUMA
$168M
$4.26K ﹤0.01%
2,500
-57
-2% -$214
PICB icon
3672
Invesco International Corporate Bond ETF
PICB
$351M
$4.24K ﹤0.01%
191
TGLS icon
3673
Tecnoglass
TGLS
$2.01B
$4.22K ﹤0.01%
59
-13
-18% -$966
OCFC icon
3674
OceanFirst Financial
OCFC
$1.7B
$4.22K ﹤0.01%
248
-171
-41% -$3.04K
DIN icon
3675
Dine Brands
DIN
$432M
$4.21K ﹤0.01%
181
-289
-61% -$7.79K

Similar funds

US Bancorp's Q1 2025 Portfolio in Review

As of Q1 2025, US Bancorp held 4,428 positions worth $74.9B, down 2% from $76.4B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

US Bancorp's Q1 2025 filing shows 282 new, 1,508 increased, 1,702 reduced and 242 closed positions. Its largest new stake was Capital Group Dividend Growers ETF: 70,824 shares worth $2.19M. The largest sale was Eli Lilly, an estimated $549M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 14% a quarter earlier, followed by Financials and Healthcare.

  • US Bancorp's largest Q1 2025 buy was Capital Group Dividend Growers ETF: 70,824 shares worth $2.19M.
  • US Bancorp added most to Vanguard Total International Stock ETF in Q1 2025, an estimated $460M increase.
  • US Bancorp's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $549M.
  • US Bancorp fully exited Aspen Technology Inc in Q1 2025, selling an estimated $3.17M.
  • US Bancorp's ten largest holdings make up 34% of its $74.9B portfolio in Q1 2025.
  • US Bancorp opened 282 new positions and closed 242 in Q1 2025.
  • US Bancorp's portfolio value fell 2% quarter-over-quarter to $74.9B.

Based on US Bancorp's 13F filing for Q1 2025, filed 8 May 2025.